SEC Form 4 · accession 0001209191-15-025605
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
G Bradley Cole
Officer — COO
Period of report
Mar 10, 2015
Accepted (ET)
Mar 12, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 10, 2015 | M | 3,600 | $9.39 | A | 33,258 | D | |
| Common Stock | Mar 10, 2015 | M | 400 | $9.39 | A | 33,658 | D | |
| Common StockF1,F2,F3,F4 | Mar 10, 2015 | S | 3,600 | $31.7702 | D | 30,058 | D | |
| Common StockF1,F3,F5,F4 | Mar 10, 2015 | S | 400 | $32.5078 | D | 29,658 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F6 | $9.39 | Mar 10, 2015 | M | 3,600 | D | — | Dec 1, 2015 | Common Stock | 3,600 | 26,064 | D |
| Employee Stock Option (right to buy)F6 | $9.39 | Mar 10, 2015 | M | 400 | D | — | Dec 1, 2015 | Common Stock | 400 | 25,664 | D |
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 24, 2014.
- F2Represents weighted average sale price. Actual sale prices ranged from $31.43 to $32.42.
- F3Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- F4Includes an aggregate of 16,201 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based vesting restricted stock units awards that have not vested.
- F5Represents weighted average sale price. Actual sale prices ranged from $32.44 to $32.64.
- F6The option became exercisable as to 25% of the shares on December 1, 2006, and becomes exercisable as to 1/48th of the shares each full month thereafter.